EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

An Interventional Response Phenotyping Study in Chronic Low Back Pain: Protocol for a Mechanistic Randomized Controlled Trial

Afton L Hassett iD, David A Williams, Richard E Harris, Steven E Harte, Chelsea M Kaplan, Andrew Schrepf, Anna L Kratz, Chad M Brummett, Kelley M Kidwell, Alexander Tsodikov, Sana Shaikh, Susan L Murphy und 15 weitere

Pain Medicine · 2023

DOI: 10.1093/pm/pnad005 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pain Medicine, 2023. Verfasst von Afton L Hassett und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University of Michigan, Ann Arbor, MI 48106, United States. Hauptthemen laut MEDLINE: Chronic Pain, Low Back Pain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evidence-based treatments for chronic low back pain (cLBP) typically work well in only a fraction of patients, and at present there is little guidance regarding what treatment should be used in which patients. Our central hypothesis is that an interventional response phenotyping study can identify individuals with different underlying mechanisms for their pain who thus respond differentially to evidence-based treatments for cLBP. Thus, we will conduct a randomized controlled Sequential, Multiple Assessment, Randomized Trial (SMART) design study in cLBP with the following three aims. Aim 1: Perform an interventional response phenotyping study in a cohort of cLBP patients (n = 400), who will receive a sequence of interventions known to be effective in cLBP. For 4 weeks, all cLBP participants will receive a web-based pain self-management program as part of a run-in period, then individuals who report no or minimal improvement will be randomized to: a) mindfulness-based stress reduction, b) physical therapy and exercise, c) acupressure self-management, and d) duloxetine. After 8 weeks, individuals who remain symptomatic will be re-randomized to a different treatment for an additional 8 weeks. Using those data, we will identify the subsets of participants that respond to each treatment. In Aim 2, we will show that currently available, clinically derived measures, can predict differential responsiveness to the treatments. In Aim 3, a subset of participants will receive deeper phenotyping (n = 160), to identify new experimental measures that predict differential responsiveness to the treatments, as well as to infer mechanisms of action. Deep phenotyping will include functional neuroimaging, quantitative sensory testing, measures of inflammation, and measures of autonomic tone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainLow Back PainHumansPhysical Therapy ModalitiesResearch DesignDuloxetine HydrochlorideTreatment OutcomeRandomized Controlled Trials as Topic

Substanzen

Duloxetine Hydrochloride

Autor:innen und Institutionen

  • Department of Anesthesiology, University of Michigan, Ann Arbor, MI 48106, United States.
  • Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI 48109, United States.
  • Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, United States.
  • Department of Radiology, University of Michigan, Ann Arbor, MI 48109, United States.
  • Department of Psychiatry, Ohio State University, Columbus, OH 43210, United States.
  • Department of Psychiatry, University of Michigan, Ann Arbor, MI 48109, United States.

ORCID-Profile: Afton L Hassett, Jenna McAfee

Förderung

  • NIAMS NIH HHS
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • University of Michigan BACPAC Mechanistic Research Center

Zitieren

APA

Hassett, A. L., Williams, D. A., Harris, R. E., Harte, S. E., Kaplan, C. M., Schrepf, A., Kratz, A. L., Brummett, C. M., Kidwell, K. M., Tsodikov, A., Shaikh, S., Murphy, S. L., Lobo, R., King, A., Favorite, T., Fisher, L., Golmirzaie, G. M., Kohns, D. J., Schneiderhan, J. R., …, & Clauw, D. J. (2023). An Interventional Response Phenotyping Study in Chronic Low Back Pain: Protocol for a Mechanistic Randomized Controlled Trial. Pain Medicine. https://doi.org/10.1093/pm/pnad005

Vancouver

Hassett AL, Williams DA, Harris RE, Harte SE, Kaplan CM, Schrepf A, et al. An Interventional Response Phenotyping Study in Chronic Low Back Pain: Protocol for a Mechanistic Randomized Controlled Trial. Pain Medicine. 2023. doi:10.1093/pm/pnad005

BibTeX
@article{Hassett2023,
  author = {Hassett, Afton L and Williams, David A and Harris, Richard E and Harte, Steven E and Kaplan, Chelsea M and Schrepf, Andrew and Kratz, Anna L and Brummett, Chad M and Kidwell, Kelley M and Tsodikov, Alexander and Shaikh, Sana and Murphy, Susan L and Lobo, Remy and King, Anthony and Favorite, Todd and Fisher, Laura and Golmirzaie, Goodarz M and Kohns, David J and Schneiderhan, Jill R and Mawla, Ishtiaq and Ichesco, Eric and McAfee, Jenna and Wasserman, Ronald A and Banner, Elizabeth and Scott, Kathy A and Cole, Courtney and Clauw, Daniel J},
  title = {An Interventional Response Phenotyping Study in Chronic Low Back Pain: Protocol for a Mechanistic Randomized Controlled Trial},
  journal = {Pain Medicine},
  year = {2023},
  doi = {10.1093/pm/pnad005}
}
Kostenlos starten →